Telmisartan/Amlodipine Tablets 40/5mg

Adult dose

The recommended dosage of this medication is 1 tablet once a day, to be taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). In patients with renal impairment, start with a lower dose and gradually increase. For patients with liver impairment, the daily dose should not exceed 40 milligrams. Elderly patients (75 years or older) should also start with a lower dose and gradually increase.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established; therefore, use in this population is not recommended.

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters; therefore, it should not be taken by women who are pregnant or may become pregnant. If pregnancy is confirmed, discontinue use immediately and switch to another safe treatment method. This medication should also not be administered to patients with certain medical conditions, such as liver impairment, biliary obstruction, severe aortic stenosis, in shock status, or those with diabetes or moderate to severe renal impairment. Patients with primary aldosteronism, heart valve diseases, impaired liver function, gastrointestinal disorders, renovascular hypertension, hypotension, dialysis-requiring renal failure, and elderly patients should use this medication with caution. Common side effects while taking this medication include dizziness or peripheral edema, so caution is needed. Rarely, symptoms such as irregular heartbeat, liver dysfunction, skin rash, myalgia, and renal dysfunction may occur. This medication may interact with other drugs; therefore, especially when taken with digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, consultation with a healthcare professional is essential. Due to the risk of hyperkalemia, it is important to regularly check potassium levels in the blood. Women who are breastfeeding are advised not to take this medication, and safety data in pediatric patients is insufficient, so it is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, and immediate medical assistance should be sought. This medication should be stored out of reach of children and kept in its original packaging.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, mouth/eye mucosal pain, difficulty breathing or shortness of breath, asthma attack, respiratory distress with cough and fever, jaundice (yellowing of skin or eyes), profound fatigue, sudden and severe headache, thunderclap headache, seizures, altered consciousness, vision problems, paralysis

Mild side effects

• Dizziness
• peripheral edema
• fainting
• headache
• drowsiness
• migraine
• sensory disturbances
• altered taste
• tremor
• visual disturbances

This medication is sensitive to light, so it should be stored in a light-protective and tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance

White and pale gray, double convex oval tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]